Sugi Predict

Sugi Predict / Compounds / SCHEMBL18529189

SCHEMBL18529189

SCHEMBL18529189

CC1(O)OC(=O)C=C1c1ccccc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCAR2 Q8TDS4 2/20 0.38
▸ NOTUM Q6P988 1/20 0.37
▸ HCAR3 P49019 1/20 0.37
▸ CA1 P00915 3/20 0.37
▸ CA2 P00918 3/20 0.37
▸ CA9 Q16790 3/20 0.37
▸ CA7 P43166 2/20 0.37
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ MAPT P10636 1/20 0.36
▸ ALDH1A1 P00352 3/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C9 P11712 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ NMUR2 Q9GZQ4 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ PGR P06401 3/20 0.34
▸ TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30762781 1.00 HCAR2 (0.38) HCAR2NOTUMHCAR3CA1CA2
SCHEMBL21543537 0.81 CA1 (0.37) CA1CA2CA9CA7MEN1
SCHEMBL30762808 0.81 CA1 (0.37) CA1CA2CA9CA7MEN1
SCHEMBL18713910 0.76 SMN1; SMN2 (0.40) HCAR2HCAR3MEN1KMT2AMAPT
SCHEMBL4651083 0.76 SMN1; SMN2 (0.40) HCAR2HCAR3MEN1KMT2AMAPT
SCHEMBL28999742 0.73 PTGS2 (0.43) HCAR2NOTUMHCAR3ALDH1A1PGR
SCHEMBL18543626 0.69 ESR2 (0.39) CA1CA2CA9CA7MEN1
SCHEMBL23961879 0.67 PGR (0.36) NOTUMCA1CA2MEN1KMT2A
SCHEMBL18530070 0.67 ALDH1A1 (0.43) NOTUMMEN1KMT2AMAPTALDH1A1
SCHEMBL18529211 0.67 PTGS2 (0.43) MEN1KMT2ANPSR1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240050430-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. 2024-02-15 — — US disclosed
EP-3788038-B1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC (US) 2023-10-11 — — EP disclosed
EP-3788038-B1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC (US) 2023-10-11 — — EP disclosed
US-11766436-B2 KRAS G12C inhibitors and methods of using the same AMGEN INC. (US) 2023-09-26 — — US disclosed
US-11766436-B2 KRAS G12C inhibitors and methods of using the same AMGEN INC. (US) 2023-09-26 — — US disclosed
US-20220395504-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. 2022-12-15 — — US disclosed
US-11090304-B2 KRAS G12C inhibitors and methods of using the same AMGEN INC. (US) 2021-08-17 — — US disclosed
US-11090304-B2 KRAS G12C inhibitors and methods of using the same AMGEN INC. (US) 2021-08-17 — — US disclosed
CN-107848968-B Process for preparing lactams from glyoxylic acid 荷兰联合利华有限公司 2021-06-18 — — CN disclosed
EP-3788038-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME Amgen Inc. (US) 2021-03-10 — — EP disclosed
EP-3337785-B1 PROCESS FOR THE PREPARATION OF LACTAMS FROM GLYOXYLIC ACID UNILEVER PLC (GB) 2020-03-18 — — EP disclosed
EP-3337785-B1 PROCESS FOR THE PREPARATION OF LACTAMS FROM GLYOXYLIC ACID UNILEVER PLC (GB) 2020-03-18 — — EP disclosed
US-20190343838-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. 2019-11-14 — — US disclosed
US-20190343838-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME AMGEN INC. 2019-11-14 — — US disclosed
US-10377707-B2 Process for the preparation of lactams from glyoxalic acid CONOPCO INC. (US) 2019-08-13 — — US disclosed
US-10377707-B2 Process for the preparation of lactams from glyoxalic acid CONOPCO INC. (US) 2019-08-13 — — US disclosed
US-20180237388-A1 PROCESS FOR THE PREPARATION OF LACTAMS FROM GLYCOXYLIC ACID Conopco, Inc., a/b/a UNILEVER (US) 2018-08-23 — — US disclosed
EP-3337785-A1 PROCESS FOR THE PREPARATION OF LACTAMS FROM GLYOXYLIC ACID Unilever PLC (GB) 2018-06-27 — — EP disclosed
WO-2017029104-A1 PROCESS FOR THE PREPARATION OF LACTAMS FROM GLYOXYLIC ACID UNILEVER PLC (GB) 2017-02-23 — — WO disclosed
WO-2017029104-A1 PROCESS FOR THE PREPARATION OF LACTAMS FROM GLYOXYLIC ACID UNILEVER PLC (GB) 2017-02-23 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190343838-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME KRAS, NRAS, HRAS HCAR2 4017/4885NOTUM 1683/4885HCAR3 4020/4885
US-11090304-B2 KRAS G12C inhibitors and methods of using the same KRAS, NRAS, HRAS HCAR2 4017/4885NOTUM 1683/4885HCAR3 4020/4885
US-20220395504-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME KRAS, NRAS, HRAS HCAR2 4017/4885NOTUM 1683/4885HCAR3 4020/4885
US-20240050430-A1 KRAS G12C INHIBITORS AND METHODS OF USING THE SAME KRAS, NRAS, HRAS HCAR2 4017/4885NOTUM 1683/4885HCAR3 4020/4885
US-10377707-B2 Process for the preparation of lactams from glyoxalic acid GLO1, PGLS, GRHPR HCAR2 2379/4885NOTUM 706/4885HCAR3 3432/4885
US-20180237388-A1 PROCESS FOR THE PREPARATION OF LACTAMS FROM GLYCOXYLIC ACID PGLS, MGAM, GLA HCAR2 2320/4885NOTUM 1178/4885HCAR3 3135/4885
US-11766436-B2 KRAS G12C inhibitors and methods of using the same KRAS, NRAS, HRAS HCAR2 4017/4885NOTUM 1683/4885HCAR3 4020/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.